Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium.
about
Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trialDisparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus.
P2860
Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Moderate to severe HIV-associa ...... o-controlled trial of lithium.
@en
Moderate to severe HIV-associa ...... o-controlled trial of lithium.
@nl
type
label
Moderate to severe HIV-associa ...... o-controlled trial of lithium.
@en
Moderate to severe HIV-associa ...... o-controlled trial of lithium.
@nl
prefLabel
Moderate to severe HIV-associa ...... o-controlled trial of lithium.
@en
Moderate to severe HIV-associa ...... o-controlled trial of lithium.
@nl
P2093
P2860
P50
P1433
P1476
Moderate to severe HIV-associa ...... bo-controlled trial of lithium
@en
P2093
Carla Freeman
Eleni Koutsilieri
Martine Casson-Crook
P2860
P356
10.1097/MD.0000000000005401
P407
P577
2016-11-01T00:00:00Z